These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 11221883

  • 1. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.
    Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S.
    Cancer Res; 2001 Feb 01; 61(3):921-5. PubMed ID: 11221883
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A, Fraizer GC, Piantanelli L, Saunders GF.
    Anticancer Res; 2001 Feb 01; 21(1A):1-10. PubMed ID: 11299720
    [Abstract] [Full Text] [Related]

  • 3. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H.
    J Mol Endocrinol; 2005 Aug 01; 35(1):135-44. PubMed ID: 16087727
    [Abstract] [Full Text] [Related]

  • 4. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C, McGee SB, Cornwell MM.
    Cell Growth Differ; 1999 Jun 01; 10(6):377-86. PubMed ID: 10392899
    [Abstract] [Full Text] [Related]

  • 5. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
    Kleymenova EV, Yuan X, LaBate ME, Walker CL.
    Oncogene; 1998 Feb 12; 16(6):713-20. PubMed ID: 9488035
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V, Kranenburg O, van der Eb AJ, Jochemsen AG.
    Cell Growth Differ; 1997 Feb 12; 8(2):133-43. PubMed ID: 9040935
    [Abstract] [Full Text] [Related]

  • 7. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
    Breast Cancer Res; 2007 Feb 12; 9(4):R43. PubMed ID: 17634147
    [Abstract] [Full Text] [Related]

  • 8. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J.
    Oncogene; 1996 Aug 01; 13(3):447-53. PubMed ID: 8760285
    [Abstract] [Full Text] [Related]

  • 9. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 2000 Feb 10; 19(6):791-800. PubMed ID: 10698497
    [Abstract] [Full Text] [Related]

  • 10. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.
    Clin Cancer Res; 2003 Dec 15; 9(17):6389-94. PubMed ID: 14695139
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X, Xing G, Saunders GF.
    Anticancer Res; 1999 Nov 06; 19(3A):1641-8. PubMed ID: 10470095
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.
    Jandrig B, Seitz S, Hinzmann B, Arnold W, Micheel B, Koelble K, Siebert R, Schwartz A, Ruecker K, Schlag PM, Scherneck S, Rosenthal A.
    Oncogene; 2004 Dec 09; 23(57):9295-302. PubMed ID: 15489893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB, Cohn SL, Tomlinson GE, Strong LC, Huff V.
    Oncogene; 1996 Sep 19; 13(6):1179-85. PubMed ID: 8808692
    [Abstract] [Full Text] [Related]

  • 20. The tumor suppressor gene WT1 inhibits ras-mediated transformation.
    Luo XN, Reddy JC, Yeyati PL, Idris AH, Hosono S, Haber DA, Licht JD, Atweh GF.
    Oncogene; 1995 Aug 17; 11(4):743-50. PubMed ID: 7651738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.